BioCentury
ARTICLE | Finance

Nautilus raises $76M series B to deliver next-generation proteomics to the lab

May 22, 2020 12:29 AM UTC

Looking to elevate the proteome to the same level as the genome for biotech R&D, Nautilus raised $76 million in a series B led to bring its proteomics platform to market.

Vulcan Capital, the investment arm of Paul Allen’s Vulcan Inc., led the untranched round. Fellow new investors Perceptive Advisors, Bezos Expeditions and Defy Partners also participated, as did existing investors AME Cloud Ventures, Andreessen Horowitz, Bolt and Madrona Venture Group...

BCIQ Company Profiles

Vulcan Capital